Refractory Status Epilepticus Clinical Trial
Official title:
A Double-blind, Randomized, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Intravenous Ganaxolone Added to Standard of Care in Refractory Status Epilepticus
This is a multicenter, double-blind, randomized, placebo-controlled study that will evaluate the efficacy, safety, and tolerability of intravenous (IV) ganaxolone versus placebo co-administered with IV antiepileptic drug (AED) according to standard of care for the treatment of RSE. Approximately 70 participants will be randomized in a 1:1 ratio to receive ganaxolone IV solution or placebo IV solution along with standard of care (SOC) IV AED.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01796574 -
Ketogenic Diet for Refractory Status Epilepticus
|
N/A | |
| Recruiting |
NCT06344338 -
Application of tDCS Stimulation in Controlling Refractory Status Epilepticus
|
N/A | |
| Not yet recruiting |
NCT05830864 -
Multicenter Retrospective Study of Isoflurane in Refractory and Super-Refractory Status Epilepticus
|
||
| Not yet recruiting |
NCT05684978 -
Efficacy and Safety of Perampanel in the Treatment of Refractory Status Epilepticus
|
Phase 4 | |
| Recruiting |
NCT05851391 -
buRst-supprESsion TO Stop Refractory Status Epilepticus Post-cardiac Arrest
|
Phase 2 | |
| Recruiting |
NCT05934903 -
Feasibility Study: tDCS for Treatment of Refractory Status Epilepticus
|
N/A | |
| Completed |
NCT04333082 -
Refractory Status Epilepticus Treatment: Quality and Efficacy of Coma Induction
|